OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of COVID‐19 in hematopoietic stem cell transplant recipients: A systematic review and meta‐analysis
Moazzam Shahzad, Sibgha Gull Chaudhary, Muhammad Usman Zafar, et al.
Transplant Infectious Disease (2022) Vol. 24, Iss. 2
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Navigating Coronavirus Disease 2019 in Immunocompromised Populations
Majd Alsoubani, Jennifer Chow
Infectious Disease Clinics of North America (2025)
Closed Access

COVID-19 and HSCT (Hematopoietic stem cell transplant)
Lynne Strasfeld
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101399-101399
Open Access | Times Cited: 19

COVID-19 Vaccination in Patients With Cancer and Patients Receiving HSCT or CAR-T Therapy: Immune Response, Real-World Effectiveness, and Implications for the Future
Victoria Hall, Benjamin W. Teh
The Journal of Infectious Diseases (2023) Vol. 228, Iss. Supplement_1, pp. S55-S69
Open Access | Times Cited: 11

Favorable outcomes of COVID‐19 in vaccinated hematopoietic stem cell transplant recipients: A single‐center experience
Jing Yuan Tan, Liang En Wee, Yi Hern Tan, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. 3
Closed Access | Times Cited: 10

Clinical outcomes and frequency of persistent infection among immunosuppressed patients treated with bebtelovimab for COVID‐19 infection at an ambulatory cancer center
Eduardo Sanchez, Elizabeth M. Krantz, Leah M. Yoke, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 1
Closed Access | Times Cited: 3

Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
Ok-Kyong Chaekal, Alexandra Gomez-Arteaga, Zhengming Chen, et al.
Transplantation and Cellular Therapy (2022) Vol. 28, Iss. 9, pp. 618.e1-618.e10
Open Access | Times Cited: 15

Respiratory virus infections after allogeneic stem cell transplantation: Current understanding, knowledge gaps, and recent advances
José Luís Piñana, Ariadna Pérez, Pedro Chorão, et al.
Transplant Infectious Disease (2023) Vol. 25, Iss. S1
Open Access | Times Cited: 8

Efficacy of SARS-CoV-2 Vaccine Doses in Allogeneic Hemopoietic Stem Cell Recipients: A Systematic Review and Meta-Analysis
Micah Rubin, Elizabeth Suelzer, Caden Ulschmid, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 2, pp. 393-399
Open Access | Times Cited: 2

Monoclonal antibodies for prophylaxis and treatment of respiratory viral infections
Jim Boonyaratanakornkit, Michael Boeckh, Alpana Waghmare
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 4, pp. 280-287
Closed Access | Times Cited: 11

COVID‐19 and primary wound healing: A new insights and advance
Danyi Li, Wenjie Cao, Qun Zhou, et al.
International Wound Journal (2023) Vol. 20, Iss. 10, pp. 4422-4428
Open Access | Times Cited: 6

Risk of Mortality in Bone Marrow Transplant Patients During SARS-CoV-2 Infection: A Systematic Review
Sonali Karhana, Kainat Hussain, Garzain Bint-E-Attar, et al.
Experimental and Clinical Transplantation (2023) Vol. 21, Iss. 1, pp. 1-11
Closed Access | Times Cited: 3

Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis
Tanaporn Meejun, Karan Srisurapanont, Kasama Manothummetha, et al.
Blood Advances (2023) Vol. 7, Iss. 18, pp. 5624-5636
Open Access | Times Cited: 3

Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients
Joe S. Al-Ramahi, Moazzam Shahzad, Kevin Li, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2023) Vol. 64, Iss. 12, pp. 1981-1991
Closed Access | Times Cited: 2

Quality of life and financial toxicity of hematopoietic stem cell transplant recipients in COVID-19
Natália Naome Oshiro, Luciana de Alcântara Nogueira, Yasmin Hiorrana dos Santos, et al.
Revista Latino-Americana de Enfermagem (2023) Vol. 31
Open Access | Times Cited: 2

Impact of Memory T Cells on SARS-COV-2 Vaccine Response in Hematopoietic Stem Cell Transplant
Jennifer VanOudenhove, Yuxin Liu, Raman Nelakanti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2

Impact of COVID-19 pandemic on cord blood banking and transplantation
Liane Marise Röhsig, Nance Beyer Nardi
Cell and Tissue Banking (2024) Vol. 25, Iss. 2, pp. 605-611
Closed Access

Severe acute respiratory syndrome coronavirus 2 infection in hematopoietic stem cell transplant recipients in Mexico City
Nancy Martínez-Rivera, Daniel Franco, Brenda L. Acosta‐Maldonado, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 4
Closed Access

COVID-19 surveillance in a bone marrow transplantation unit: experience from a Brazilian tertiary-care teaching hospital
Bruno Azevedo Randi, Thaís Guimarães, Fernanda Spadão, et al.
Supportive Care in Cancer (2024) Vol. 32, Iss. 4
Closed Access

COVID-19 impact in Crohn’s disease patients submitted to autologous hematopoietic stem cell transplantation
Milton Artur Ruiz, Roberto Luiz Kaiser, Lílian Piron-Ruiz, et al.
World Journal of Hematology (2024) Vol. 11, Iss. 1
Open Access

THE POTENTIAL OF HUMAN PLASMA AND HUMAN BLOOD PRODUCTS FOR IMMUNE PROTECTION
Vancho Donev, Georgi Nikolov
PROBLEMS of Infectious and Parasitic Diseases (2024) Vol. 52, Iss. 1, pp. 22-28
Open Access

COVID-19 was associated with the complications after allogeneic hematopoietic stem cell transplantation
Qi Wen, Ze Guo, Xiaohui Zhang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access

Patients with multiple myeloma infected with COVID-19 during autologous stem cell transplantation
Rosaria De Filippi, Gianpaolo Marcacci, Sabrina Amelio, et al.
Infectious Agents and Cancer (2024) Vol. 19, Iss. 1
Open Access

COVID-19 in immunocompromised patients after hematopoietic stem cell transplantation: a pilot study
Zilu Zhang, Jingtao Huang, Luxiang Wang, et al.
Blood Science (2024) Vol. 6, Iss. 2, pp. e00183-e00183
Open Access

Page 1 - Next Page

Scroll to top